These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7744644)

  • 21. Prednisolone inclusion in a first-line multidrug cytostatic protocol for the treatment of canine lymphoma does not affect therapy results.
    Zandvliet M; Rutteman GR; Teske E
    Vet J; 2013 Sep; 197(3):656-61. PubMed ID: 23746872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of prognostic factors and sequential combination chemotherapy with doxorubicin for canine lymphoma.
    Keller ET; MacEwen EG; Rosenthal RC; Helfand SC; Fox LE
    J Vet Intern Med; 1993; 7(5):289-95. PubMed ID: 8263847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histologic classification as an indication of therapeutic response in malignant lymphoma of dogs.
    Gray KN; Raulston GL; Gleiser CA; Jardine JH
    J Am Vet Med Assoc; 1984 Apr; 184(7):814-7. PubMed ID: 6725115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of T cell lymphoma in dogs.
    Moore AS
    Vet Rec; 2016 Sep; 179(11):277. PubMed ID: 27634860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination chemotherapy with continuous L-asparaginase, lomustine, and prednisone for relapsed canine lymphoma.
    Saba CF; Hafeman SD; Vail DM; Thamm DH
    J Vet Intern Med; 2009; 23(5):1058-63. PubMed ID: 19678892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome and toxicity associated with a dose-intensified, maintenance-free CHOP-based chemotherapy protocol in canine lymphoma: 130 cases.
    Sorenmo K; Overley B; Krick E; Ferrara T; LaBlanc A; Shofer F
    Vet Comp Oncol; 2010 Sep; 8(3):196-208. PubMed ID: 20691027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma.
    Moore AS; Cotter SM; Rand WM; Wood CA; Williams LE; London CA; Frimberger AE; L'Heureux DA
    J Vet Intern Med; 2001; 15(4):348-54. PubMed ID: 11467592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proof-of-concept study: Evaluation of plasma and urinary electrolytes as markers of response to L-asparaginase therapy in dogs with high-grade lymphoma.
    Sayag D; Chamel G; Bédard C; Beauchamp G; Couturier S; Ponce F; Rannou B
    Vet Clin Pathol; 2020 Sep; 49(3):476-483. PubMed ID: 32955128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechlorethamine, procarbazine and prednisone for the treatment of resistant lymphoma in dogs.
    Northrup NC; Gieger TL; Kosarek CE; Saba CF; LeRoy BE; Wall TM; Hume KR; Childress MO; Keys DA
    Vet Comp Oncol; 2009 Mar; 7(1):38-44. PubMed ID: 19222829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II clinical trial of combination chemotherapy with dexamethasone for lymphoma in dogs.
    Greenberg CB; Boria PA; Borgatti-Jeffreys A; Raskin RE; Lucroy MD
    J Am Anim Hosp Assoc; 2007; 43(1):27-32. PubMed ID: 17209082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum amyloid A is not a marker for relapse of multicentric lymphoma in dogs.
    Merlo A; Rezende BC; Franchini ML; Monteiro PR; Lucas SR
    Vet Clin Pathol; 2008 Mar; 37(1):79-85. PubMed ID: 18366549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of some prognostic factors for advanced multicentric lymphosarcoma in the dog: 147 cases (1978-1981).
    MacEwen EG; Hayes AA; Matus RE; Kurzman I
    J Am Vet Med Assoc; 1987 Mar; 190(5):564-8. PubMed ID: 3558097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP-MA) for the treatment of canine lymphoma.
    Daters AT; Mauldin GE; Mauldin GN; Brodsky EM; Post GS
    Vet Comp Oncol; 2010 Mar; 8(1):11-22. PubMed ID: 20230577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of CCNU and DTIC chemotherapy for treatment of resistant lymphoma in dogs.
    Flory AB; Rassnick KM; Al-Sarraf R; Bailey DB; Balkman CE; Kiselow MA; Autio K
    J Vet Intern Med; 2008; 22(1):164-71. PubMed ID: 18289305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential low-dose rate half-body irradiation and chemotherapy for the treatment of canine multicentric lymphoma.
    Lurie DM; Gordon IK; Théon AP; Rodriguez CO; Suter SE; Kent MS
    J Vet Intern Med; 2009; 23(5):1064-70. PubMed ID: 19627472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of a continuous, multiagent chemotherapeutic protocol versus a short-term single-agent protocol in dogs with lymphoma.
    Simon D; Moreno SN; Hirschberger J; Moritz A; Kohn B; Neumann S; Jurina K; Scharvogel S; Schwedes C; Reinacher M; Beyerbach M; Nolte I
    J Am Vet Med Assoc; 2008 Mar; 232(6):879-85. PubMed ID: 18341445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic role of the updated Kiel classification in canine high-grade T-cell lymphomas.
    Jankowska U; Jagielski D; Czopowicz M; Sapierzyński R
    Vet Med Sci; 2024 Jul; 10(4):e1398. PubMed ID: 38767567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective evaluation of the safety of compounded bulk material L-asparaginase in dogs with lymphoma.
    Thiman J; Northrup N; Saba C; Clarke D; Regan R; Hamilton T; Lindell H; Hofmeister E
    J Vet Pharmacol Ther; 2016 Dec; 39(6):572-577. PubMed ID: 27086733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The staging and treatment of multicentric high-grade lymphoma in dogs: a review of recent developments and future prospects.
    Marconato L
    Vet J; 2011 Apr; 188(1):34-8. PubMed ID: 20627636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.